医学
细胞减少术
卵巢癌
肿瘤科
区间(图论)
临床疗效
内科学
妇科
外科
癌症
数学
组合数学
作者
Cláudia Marchetti,Raffaella Ergasti,Filippo Maria Capomacchia,Diana Giannarelli,Luca Mastrantoni,Francesco Pepe,Adriana Ionelia Apostol,Carolina Maria Sassu,Camilla Nero,Alessia Piermattei,Gian Franco Zannoni,Giancarlo Troncone,Olivier Colomban,Gianluca Russo,Aurore Carrot,Umberto Malapelle,Benoît You,Domenica Lorusso,Giovanni Scambia,Anna Fagotti
标识
DOI:10.1016/j.ygyno.2025.02.016
摘要
CRS is a prognostic factor in PARPi-treated population as a PARPi efficacy surrogate. Integrating HRD status, CRS, and KELIM allows patients risk stratification and tailored maintenance. These results should be considered hypothesis-generating.
科研通智能强力驱动
Strongly Powered by AbleSci AI